T cell‐replacing factor in specific antibody responses to influenza virus by human blood B cells
- 1 January 1985
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 15 (1) , 52-59
- https://doi.org/10.1002/eji.1830150111
Abstract
In man, B cell maturation factors obtained from T cells or T cell lines have been shown to induce antibody formation in mitogen or anti‐immunoglobulin activated B cells, and in some continuous B cell lines, but the relationships between these factors and B cell differentiation factors in antigen‐specific antibody responses is unclear. We have now shown that supernatants from phytohemagglutinin‐activated tonsil cells, or from the Gibbon Ape T cell line ML A‐144, can substitute for T cells in the specific antibody response by human blood B cells to influenza virus. Thus, T cell‐depleted non‐rosette‐forming (E−) cells prepared from peripheral blood mononuclear cells made antibody when cultured with antigen and factor together, whereas control cultures of E− cells with either antigen or factor alone did not. Moreover, E− cells cultured with factor and influenza virus strain A/X31 made antibody to A/X31, but not the non‐cross‐reacting strain, B/HK (and vice versa)showing that the response was antigen specific. The activity in these supernatants, therefore, fulfilled the functional definition of T cell‐replacing factor (TRF). The possibility that interleukin 2 (IL2) present in the TRF‐containing supernatants was expanding residual T cells in the E− preparations to provide normal T cell help was excluded in three different ways. First, E− cells depleted of T (Leu4+) cells to undetectable levels made normal amounts of antibody when cultured with antigen and TRF. Secondly, a limiting dilution technique was employed to show that help in cultures of E− cells and TRF was not mediated by antigen‐specific T helper cells. Thirdly, TRF‐containing supernatants depleted of IL2 retained activity, whereas purified IL2 was inactive. Preliminary purification of TRF by gel filtration on Ultrogel AcA54 columns showed that all the activity eluted in a single peak between 35000 and 43000 molecular weight. This distinguishes human TRF from IL2 and from other B cell maturation factors with a molecular weight range of 15000–20000 which act on continuous B cell lines.In addition to TRF, supernatants from phytohemagglutinin‐activated tonsils also contained a factor which could induce polyspecific IgM production, but only in cultures containing significant numbers of T cells. This additional activity may have been due to IL2, and provides an explanation for the apparent T cell‐dependent effects sometimes observed in experiments designed to test B cell differentiation factors on T cell‐ depleted normal B cells.This publication has 37 references indexed in Scilit:
- Regulation of B-Cell Growth and Differentiation by Soluble FactorsAnnual Review of Immunology, 1983
- Lymphokine-induced IgM secretion by clones of neoplastic B cellsNature, 1983
- Clonal differences in response to T cell replacing factor (TRF) for IgM secretion and TRF receptors in a human B lymphoblast cell lineEuropean Journal of Immunology, 1983
- A monoclonal T cell-replacing activity can act directly on B cells to enhance clonal expansion.The Journal of Experimental Medicine, 1982
- Major histocompatibility complex‐restricted cellular interactions determining B cell activationEuropean Journal of Immunology, 1982
- B cell helper factors. I. Requirement for both interleukin 2 and another 40,000 mol wt factor.The Journal of Experimental Medicine, 1981
- T cell growth factor receptors. Quantitation, specificity, and biological relevanceThe Journal of Experimental Medicine, 1981
- Histocompatibility requirements for T cell help in specific in vitro antibody responses to influenza virus by human blood lymphocytesEuropean Journal of Immunology, 1981
- Specific in vitro antibody response to influenza virus by human blood lymphocytesNature, 1979
- Biochemical and biological characterization of lymphocyte regulatory molecules. I. Purification of a class of murine lymphokines.The Journal of Experimental Medicine, 1979